RT Journal Article
SR Electronic
T1 Hospital environments harbor chlorhexidine tolerant bacteria potentially linked to chlorhexidine persistence in the environment
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.10.07.24315058
DO 10.1101/2024.10.07.24315058
A1 Shen, Jiaxian
A1 Weng, Yuhan
A1 Shimada, Tyler
A1 Karan, Meghana
A1 Watson, Andrew
A1 Medernach, Rachel L.
A1 Young, Vincent B.
A1 Hayden, Mary K.
A1 Hartmann, Erica M.
YR 2024
UL http://medrxiv.org/content/early/2024/10/08/2024.10.07.24315058.abstract
AB A One Health approach is essential in combating antibiotic and antimicrobial resistance. Chlorhexidine (di)gluconate (CHG), a widely used antiseptic in medical intensive care units (MICU), has recently come under scrutiny. However, studies on CHG tolerance, particularly in interconnected indoor environments, are limited. We comprehensively explored CHG tolerance in MICU environments from chemical, microbial, and molecular perspectives. Using microcosm experiments and field surveys, we demonstrated that CHG, if transferred from patient skin to environments, can persist on surfaces despite cleaning and disinfection and decrease to sublethal levels for clinically relevant bacteria. We detected widespread CHG-tolerant bacteria (≥ 18.75 µg/mL), including opportunistic pathogens (e.g., Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Elizabethkingia miricola), with minimum inhibitory concentrations up to 512 μg/mL. Sink drains emerged as critical hotspots, and indoor air as a potential transport mechanism. We observed indications of bacterial persistence, increased tolerance, in-situ evolution, and dissemination across MICU rooms. Molecular analyses revealed heterogeneous and largely unexplored CHG resistance mechanisms and identified resistance determinant candidates, particularly qacEdelta1-carrying, plasmid-borne multidrug-resistant cassettes. Our findings underscore the importance of understanding human-environment and chemical-microbe interactions to preserve chlorhexidine’s efficacy and inform infection prevention strategies. We advocate for integrated environmental management and clinical interventions under the One Health framework.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was partially supported by the Searle Leadership Fund and the Northwestern University 2020 NUSeq Pilot Project Program. Additionally, the computational resources and staff contributions provided by the Quest high performance computing facility at Northwestern University, which is jointly supported by the Office of the Provost, the Office for Research, and Northwestern University Information Technology, were instrumental. JS was supported by Northwestern University Terminal Year Fellowship from the Richter Memorial Fund. Undergraduate researchers received support from Northwestern University Undergraduate Research Grants: AW from the Buffett Institute, MK from the Weinberg College of Arts and Sciences Summer Undergraduate Research Grant, and YW and YS from the Office of Undergraduate Research Summer Undergraduate Research Grant.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe raw whole genome sequencing data of bacteria isolates are available in the NCBI SRA repository under BioProject number PRJNA1169385. The data will be accessible upon manuscript acceptance. Source code for the analyses are available under MIT license at https://github.com/hartmann-lab/Chlorhexidine_Tolerance_Hospital_Environments. Bacteria isolates are available upon request (erica.hartmann{at}northwestern.edu).